|
Name |
enellin-N-(4-O-methyl)-β-D-glucopyranoside
|
| Molecular Formula | C28H35NO10 | |
| IUPAC Name* |
1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-5-(4,6-dimethylocta-2,4-dienoyl)-4-hydroxy-3-(4-hydroxyphenyl)pyridin-2-one
|
|
| SMILES |
CCC(C)C=C(C)C=CC(=O)c1cn(OC2OC(CO)C(OC)C(O)C2O)c(=O)c(-c2ccc(O)cc2)c1O
|
|
| InChI |
InChI=1S/C28H35NO10/c1-5-15(2)12-16(3)6-11-20(32)19-13-29(27(36)22(23(19)33)17-7-9-18(31)10-8-17)39-28-25(35)24(34)26(37-4)21(14-30)38-28/h6-13,15,21,24-26,28,30-31,33-35H,5,14H2,1-4H3/b11-6+,16-12+/t15-,21-,24-,25-,26-,28+/m1/s1
|
|
| InChIKey |
ZCRWBZMWDINYNN-SZKWZXLKSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 545.59 | ALogp: | 1.5 |
| HBD: | 5 | HBA: | 11 |
| Rotatable Bonds: | 10 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 167.9 | Aromatic Rings: | 3 |
| Heavy Atoms: | 39 | QED Weighted: | 0.169 |
| Caco-2 Permeability: | -5.455 | MDCK Permeability: | 0.00000364 |
| Pgp-inhibitor: | 0.025 | Pgp-substrate: | 0.962 |
| Human Intestinal Absorption (HIA): | 0.958 | 20% Bioavailability (F20%): | 0.011 |
| 30% Bioavailability (F30%): | 0.887 |
| Blood-Brain-Barrier Penetration (BBB): | 0.155 | Plasma Protein Binding (PPB): | 90.72% |
| Volume Distribution (VD): | 0.676 | Fu: | 7.62% |
| CYP1A2-inhibitor: | 0.026 | CYP1A2-substrate: | 0.091 |
| CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.179 |
| CYP2C9-inhibitor: | 0.022 | CYP2C9-substrate: | 0.608 |
| CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.258 |
| CYP3A4-inhibitor: | 0.071 | CYP3A4-substrate: | 0.176 |
| Clearance (CL): | 1.45 | Half-life (T1/2): | 0.474 |
| hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.274 |
| Drug-inuced Liver Injury (DILI): | 0.776 | AMES Toxicity: | 0.111 |
| Rat Oral Acute Toxicity: | 0.081 | Maximum Recommended Daily Dose: | 0.344 |
| Skin Sensitization: | 0.061 | Carcinogencity: | 0.301 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
| Respiratory Toxicity: | 0.025 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005615 | ![]() |
0.395 | D06BQU | ![]() |
0.268 | ||
| ENC002582 | ![]() |
0.367 | D0Q0PR | ![]() |
0.264 | ||
| ENC004475 | ![]() |
0.362 | D08DFX | ![]() |
0.261 | ||
| ENC003476 | ![]() |
0.361 | D01TNW | ![]() |
0.260 | ||
| ENC003004 | ![]() |
0.361 | D0T5XN | ![]() |
0.253 | ||
| ENC004476 | ![]() |
0.357 | D0TC7C | ![]() |
0.246 | ||
| ENC004958 | ![]() |
0.352 | D0I9HF | ![]() |
0.244 | ||
| ENC004073 | ![]() |
0.331 | D0AZ8C | ![]() |
0.244 | ||
| ENC004802 | ![]() |
0.328 | D0C9XJ | ![]() |
0.240 | ||
| ENC005772 | ![]() |
0.328 | D07VLY | ![]() |
0.240 | ||